Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)-Reference-Cited by-同舟云学术

Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)

Published:2015-03-30 Issue:1 Volume:170 Page:56-65
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Swinnen Lode J.¹,Li Hailun²,Quon Andrew³,Gascoyne Randy⁴,Hong Fangxin²,Ranheim Erik A.⁵,Habermann Thomas M.⁶,Kahl Brad S.⁵,Horning Sandra J.⁷,Advani Ranjana H.³

Affiliation:

1. Department of Oncology; Johns Hopkins University; Baltimore MD USA

2. Dana Farber Cancer Institute; Boston MA USA

3. Stanford University Medical Center; Stanford CA USA

4. British Columbia Cancer Agency; Centre for Lymphoid Cancer; Vancouver BC Canada

5. University of Wisconsin; Madison WI USA

6. Mayo Clinic; Rochester MN USA

7. Stanford University; Stanford CA USA

Funder

National Institutes of Health

U.S. Public Health Service

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13389/fullpdf

Reference40 articles.

1. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group;Barrington;Journal of Clinical Oncology,2014

2. 18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation;Cashen;Journal of Nuclear Medicine,2011

3. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology,1999

4. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;New England Journal of Medicine,2002

5. Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative study;Fruchart;Leukaemia & Lymphoma,2006

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Значение ПЭТ, совмещенной с КТ, при диффузной В-крупноклеточной лимфоме: история вопроса, эволюция представлений и современные возможности метода (обзор литературы);Clinical Oncohematology;2024-02-20

2. 中期PET-CT在淋巴瘤一线治疗决策中的应用;Journal of Zhejiang University-SCIENCE B;2023-10

3. Cell-free DNA in large B-cell lymphoma: MRD and beyond;Seminars in Hematology;2023-07

4. PET/CT in Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05

5. Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis;Cancer Medicine;2023-02-17